JP2023089103A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023089103A5 JP2023089103A5 JP2023063975A JP2023063975A JP2023089103A5 JP 2023089103 A5 JP2023089103 A5 JP 2023089103A5 JP 2023063975 A JP2023063975 A JP 2023063975A JP 2023063975 A JP2023063975 A JP 2023063975A JP 2023089103 A5 JP2023089103 A5 JP 2023089103A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- vector
- collection
- pharmaceutical composition
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013598 vector Substances 0.000 claims 16
- 229920001184 polypeptide Polymers 0.000 claims 13
- 102000004196 processed proteins & peptides Human genes 0.000 claims 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims 13
- 102000040430 polynucleotide Human genes 0.000 claims 8
- 108091033319 polynucleotide Proteins 0.000 claims 8
- 239000002157 polynucleotide Substances 0.000 claims 8
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 5
- 201000011510 cancer Diseases 0.000 claims 4
- 230000000890 antigenic effect Effects 0.000 claims 3
- 210000000056 organ Anatomy 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 230000001850 reproductive effect Effects 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 108010077805 Bacterial Proteins Proteins 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 230000005867 T cell response Effects 0.000 claims 1
- 108010067390 Viral Proteins Proteins 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 210000001188 articular cartilage Anatomy 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 claims 1
- 210000000133 brain stem Anatomy 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 210000002249 digestive system Anatomy 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000003372 endocrine gland Anatomy 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- 108010028930 invariant chain Proteins 0.000 claims 1
- 210000000088 lip Anatomy 0.000 claims 1
- 210000003563 lymphoid tissue Anatomy 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 210000000214 mouth Anatomy 0.000 claims 1
- 210000003800 pharynx Anatomy 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 210000002345 respiratory system Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000004872 soft tissue Anatomy 0.000 claims 1
- 210000001685 thyroid gland Anatomy 0.000 claims 1
- 210000001635 urinary tract Anatomy 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17200036.6 | 2017-11-03 | ||
| EP17200036 | 2017-11-03 | ||
| EP17211235 | 2017-12-29 | ||
| PCT/EP2018/080027 WO2019086615A1 (en) | 2017-11-03 | 2018-11-02 | Vaccine t cell enhancer |
| JP2020524616A JP7386537B2 (ja) | 2017-11-03 | 2018-11-02 | ワクチンｔ細胞エンハンサー |
| EP17211235.1 | 2019-05-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524616A Division JP7386537B2 (ja) | 2017-11-03 | 2018-11-02 | ワクチンｔ細胞エンハンサー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023089103A JP2023089103A (ja) | 2023-06-27 |
| JP2023089103A5 true JP2023089103A5 (enExample) | 2024-03-05 |
| JP7485422B2 JP7485422B2 (ja) | 2024-05-16 |
Family
ID=64332267
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524616A Active JP7386537B2 (ja) | 2017-11-03 | 2018-11-02 | ワクチンｔ細胞エンハンサー |
| JP2023063975A Active JP7485422B2 (ja) | 2017-11-03 | 2023-04-11 | ワクチンｔ細胞エンハンサー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524616A Active JP7386537B2 (ja) | 2017-11-03 | 2018-11-02 | ワクチンｔ細胞エンハンサー |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11912743B2 (enExample) |
| EP (1) | EP3703744A1 (enExample) |
| JP (2) | JP7386537B2 (enExample) |
| KR (1) | KR102747530B1 (enExample) |
| CN (1) | CN111670046B (enExample) |
| AU (1) | AU2018358019B2 (enExample) |
| BR (1) | BR112020008308A2 (enExample) |
| CA (1) | CA3078692A1 (enExample) |
| IL (1) | IL274409B2 (enExample) |
| MX (1) | MX2020004552A (enExample) |
| SG (1) | SG11202003799RA (enExample) |
| WO (1) | WO2019086615A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12576143B2 (en) * | 2018-10-19 | 2026-03-17 | Nouscom Ag | Teleost invariant chain cancer vaccine |
| MX2021005656A (es) * | 2018-11-15 | 2021-07-07 | Nouscom Ag | Seleccion de mutaciones de cancer para la generacion de una vacuna contra cancer personalizada. |
| TWI852977B (zh) | 2019-01-10 | 2024-08-21 | 美商健生生物科技公司 | 前列腺新抗原及其用途 |
| CR20220220A (es) | 2019-11-18 | 2022-09-20 | Janssen Biotech Inc | Vacunas basadas en calr y jak2 mutantes y sus usos |
| WO2021209897A1 (en) * | 2020-04-13 | 2021-10-21 | Janssen Biotech, Inc. | Psma and steap1 vaccines and their uses |
| EP4175664A2 (en) | 2020-07-06 | 2023-05-10 | Janssen Biotech, Inc. | Prostate neoantigens and their uses |
| US20230190903A1 (en) * | 2021-12-16 | 2023-06-22 | Janssen Biotech, Inc. | Prostate cancer vaccines and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602005017743D1 (de) | 2004-01-23 | 2009-12-31 | Angeletti P Ist Richerche Bio | Impfstoffträger für schimpansen-adenovirus |
| EP3552622A3 (en) | 2008-11-21 | 2019-12-04 | Københavns Universitet (University Of Copenhagen) | Priming of an immune response |
| PL2391638T3 (pl) | 2009-02-02 | 2018-11-30 | Glaxosmithkline Biologicals Sa | Sekwencje nukleotydowe i aminokwasowe małpiego adenowirusa, zawierające je wektory i ich zastosowania |
| EA027236B1 (ru) | 2011-04-08 | 2017-07-31 | Иммьюн Дизайн Корп. | Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа |
| GB201321384D0 (en) * | 2013-12-04 | 2014-01-15 | Isis Innovation | Molecular adjuvant |
| WO2016013672A1 (ja) * | 2014-07-25 | 2016-01-28 | 国立研究開発法人理化学研究所 | メモリーインバリアントｎｋｔ細胞マーカー |
| JP7298926B2 (ja) * | 2017-07-12 | 2023-06-27 | ノイスコム アーゲー | 癌の治療のためのネオアンチゲンワクチン組成物 |
-
2018
- 2018-11-02 KR KR1020207013171A patent/KR102747530B1/ko active Active
- 2018-11-02 AU AU2018358019A patent/AU2018358019B2/en active Active
- 2018-11-02 WO PCT/EP2018/080027 patent/WO2019086615A1/en not_active Ceased
- 2018-11-02 MX MX2020004552A patent/MX2020004552A/es unknown
- 2018-11-02 EP EP18804240.2A patent/EP3703744A1/en active Pending
- 2018-11-02 BR BR112020008308-9A patent/BR112020008308A2/pt not_active Application Discontinuation
- 2018-11-02 IL IL274409A patent/IL274409B2/en unknown
- 2018-11-02 US US16/761,004 patent/US11912743B2/en active Active
- 2018-11-02 SG SG11202003799RA patent/SG11202003799RA/en unknown
- 2018-11-02 CN CN201880071581.4A patent/CN111670046B/zh active Active
- 2018-11-02 CA CA3078692A patent/CA3078692A1/en active Pending
- 2018-11-02 JP JP2020524616A patent/JP7386537B2/ja active Active
-
2023
- 2023-04-11 JP JP2023063975A patent/JP7485422B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023089103A5 (enExample) | ||
| AU723147B2 (en) | Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant | |
| CN105377291B (zh) | 免疫原性wt-1肽和其使用方法 | |
| CN1131712C (zh) | 初乳肽及其用途 | |
| JPH06508988A (ja) | 乳頭腫ウイルスｌ２蛋白 | |
| ES2365077T3 (es) | Péptido antígeno anticáncer derivado de sparc y composición farmacéutica que comprende el mismo. | |
| KR20200123696A (ko) | 인간 백혈구 항원 a24:02 대립유전자에 특이적으로 결합하는 펩타이드 및 이의 용도 | |
| TW200824705A (en) | Reconstituted surfactants having improved properties | |
| CN113880915A (zh) | 用于修复黏膜损伤或皮肤创伤的多肽及其应用 | |
| JP6293882B2 (ja) | 遺伝的に安定な腫瘍溶解性ｒｎａウイルス、その製造方法およびその使用 | |
| JP5243624B2 (ja) | 抗原ペプチドおよびその利用 | |
| GB1604850A (en) | Biologically active peptides | |
| TW434257B (en) | Proteins from mammalian liver and their use in oncology | |
| ES2390967T3 (es) | Epítopo/péptido reconocido por LTC específico para Ep-CAM con restricción por ALH-A2402 y su utilización | |
| JPH10501003A (ja) | 免疫調節作用を有する新規ペプチド | |
| CN107805282A (zh) | 一种靶向疗法和免疫疗法联合的多肽 | |
| KR20220079081A (ko) | 결핵의 예방 또는 치료용 약학적 조성물 | |
| CN114478712B (zh) | Hpv抗原表位及其鉴定方法、应用 | |
| JP2001508764A (ja) | 免疫原性ｔｌｐ組成物 | |
| Penn | Immunosuppression and cancer: importance in head and neck surgery | |
| JP6481873B2 (ja) | Ｍｕｃ１由来のペプチド、これを用いた癌の治療又は予防のための医薬組成物、免疫誘導剤、及び抗原提示細胞の製造方法 | |
| JP2001511143A (ja) | コラーゲン▲ｉｉ▼に特異的なｔ細胞エピトープを含むペプチド | |
| WO2015169225A1 (zh) | 四分支多肽化合物及其制备方法与应用 | |
| Aiyer et al. | Extranodal non-Hodgkins lymphoma of larynx | |
| CN103539840B (zh) | 表皮生长因子受体模拟表位肽及其应用 |